Normal renal function 8 to 13 years after Cyclosporin A therapy in 285 diabetic patients
- 23 October 2002
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 18 (6) , 464-472
Abstract
Background: Cyclosporin A (CyA) may induce acute nephrotoxicity. The question has been raised of the possible long‐term unfavorable course of CyA‐induced lesions. Advantage was taken of a large cohort of diabetic patients treated for several months using moderate CyA dosage to evaluate the long‐term evolution of renal function in such patients.Methods: Two hundred and eighty five recently diagnosed type 1 diabetic patients having received CyA for a mean of 19.9 months were monitored for 13 years, in parallel with 100 similar patients treated with insulin alone.Results: In the CyA‐treated group, a transient increase in creatininemia levels occurred during the first 18 months of treatment associated with a transient increase in renal vascular resistance. Both effects disappeared later on: creatininemia levels then remained normal. Inulin and p‐aminohippurate (PAH) clearances remained normal throughout follow‐up. Neither permanent renal failure nor progressive deterioration of renal function occurred in either group or in individual patients. A 10 to 12% increase in inulin and PAH clearance was elicited by IV amino acid infusion at 7 to 10 years, a finding consistent with a normal renal functional reserve. Patients with moderate kidney lesions on biopsy at 1 year had normal and stable clearance values at 7 to 13 years. The prevalence of arterial hypertension and retinopathy was lower in the CyA‐treated group than in the control group, possibly because of the tighter metabolic control obtained in the CyA group.Conclusion: These results suggest that low‐dose CyA treatment combined with thorough monitoring does not result in long‐term renal dysfunction. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 44 references indexed in Scilit:
- Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicityKidney International, 1994
- REDUCTION OF CYCLOSPORINE-INDUCED NEPHROTOXICITY BY CILASTATIN FOLLOWING CLINICAL HEART TRANSPLANTATION1Transplantation, 1994
- Time Course of the Decline in Renal Function in Cyclosporine-Treated Heart Transplant RecipientsAmerican Journal of Nephrology, 1994
- Morphologic renal changes during cyclosporine treatment of psoriasisJournal of the American Academy of Dermatology, 1992
- Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicityKidney International, 1992
- CyclosporineNew England Journal of Medicine, 1989
- Evolution of Ciclosporin Nephrotoxicity in Patients Treated for Autoimmune UveitisAmerican Journal of Nephrology, 1989
- Factors Associated with Early Remission of Type I Diabetes in Children Treated with CyclosporineNew England Journal of Medicine, 1988
- Renal Histopathologic Alterations in Patients Treated with Cyclosporine for UveitisNew England Journal of Medicine, 1986
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984